This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wuxi Shuangliang Biotechnology Co., Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Minqi Gao - Innovator in Selective CDK4/6 Inhibition
Introduction
Minqi Gao is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of selective inhibitors for cyclin-dependent kinases. His work is crucial for advancing treatments for diseases modulated by CDK4/6.
Latest Patents
Minqi Gao holds 1 patent for his invention titled "Selective CDK4/6 inhibitor and preparation thereof." This patent discloses a compound represented by a specific formula, which can be utilized as a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6). The compounds described in this patent have potential applications in treating or preventing diseases that are at least partially modulated by CDK4/6.
Career Highlights
Minqi Gao is currently associated with Wuxi Shuangliang Biotechnology Co., Ltd. His role in this company allows him to further his research and development efforts in the biotechnology sector. His innovative work has positioned him as a key figure in the field.
Collaborations
Minqi Gao collaborates with talented individuals such as Feng Fan and Jiaquan Wu. These partnerships enhance the research and development capabilities within his team, fostering an environment of innovation.
Conclusion
Minqi Gao's contributions to the field of selective CDK4/6 inhibition exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.